Stability testing ยท Protocol planning
Designing a small-molecule stability testing protocol
A practical educational checklist for defining stability study scope, sampling, testing schedules, trend review, and documentation.
Start with the study question
A useful protocol explains what decision the study will support and which records will support that decision. Before drafting a testing table, write down whether you are studying a drug substance or finished product, the development stage, intended markets, and proposed storage claim.
Use the guideline within its scope
ICH Q1A(R2) addresses registration stability studies for new drug substances and products. A drug substance may have a retest period; a drug product has a shelf life. Clinical studies, variations, and other application types need their applicable requirements checked separately.
For general-case long-term studies supporting a shelf life of at least 12 months, Q1A(R2) typically describes testing every three months in year one, every six months in year two, and annually thereafter. Thus 0, 3, 6, 9, 12, 18, and 24 months is an illustrative sequence, not a universal schedule. Refrigerated, frozen, and special packaging cases need separate consideration. Stress testing explores degradation and analytical suitability; it does not replace formal stability studies.
A drafting checklist
The following questions are an editorial planning aid, not a regulatory minimum:
- Identity: Can a reviewer trace each batch, strength, formulation, manufacturing site, and packaging configuration?
- Storage: Does each study arm name its conditions, monitoring records, and rationale?
- Samples: Who owns placement, pull dates, inventory, transport, and reconciliation?
- Testing: Are method versions, specifications, units, reporting conventions, and responsibilities explicit?
- Scheduling: Are time points and permitted handling windows documented in the approved procedure?
- Review: Who examines individual results and trends, and how are unexpected observations escalated?
- Changes: Can amendments be traced to their justification, approval, and affected samples?
Check the protocol against the eventual report
Try drafting a blank results table before approving the protocol. If you cannot tell where sample identity, actual pull date, method version, result, and deviation reference will go, the workflow needs clarification. This simple writing exercise can expose missing handoffs before samples enter a chamber.
Primary reference
ICH Q1A(R2): Stability Testing of New Drug Substances and Products, particularly scope, testing frequency, and storage conditions. Verify applicable regional requirements and revision status before operational use.